These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31640767)

  • 1. Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases?
    Dias IE; Pinto PO; Barros LC; Viegas CA; Dias IR; Carvalho PP
    BMC Vet Res; 2019 Oct; 15(1):358. PubMed ID: 31640767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of mesenchymal stem cells as a limiting factor in their clinical application to inflammatory bowel disease in dogs and cats.
    Teshima T
    Vet J; 2024 Apr; 304():106090. PubMed ID: 38417670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell therapy in cats: Current knowledge and future potential.
    Quimby JM; Borjesson DL
    J Feline Med Surg; 2018 Mar; 20(3):208-216. PubMed ID: 29478398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine amniotic membrane-derived mesenchymal stem cells ameliorate atopic dermatitis through regeneration and immunomodulation.
    Kim MS; Kong D; Han M; Roh K; Koo H; Lee S; Kang KS
    Vet Res Commun; 2023 Dec; 47(4):2055-2070. PubMed ID: 37421548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety.
    Villatoro AJ; Hermida-Prieto M; Fernández V; Fariñas F; Alcoholado C; Rodríguez-García MI; Mariñas-Pardo L; Becerra J
    Vet Rec; 2018 Dec; 183(21):654. PubMed ID: 30158120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats.
    Arzi B; Mills-Ko E; Verstraete FJ; Kol A; Walker NJ; Badgley MR; Fazel N; Murphy WJ; Vapniarsky N; Borjesson DL
    Stem Cells Transl Med; 2016 Jan; 5(1):75-86. PubMed ID: 26582907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem Cell Therapy.
    Quimby JM
    Vet Clin North Am Small Anim Pract; 2019 Mar; 49(2):223-231. PubMed ID: 30591191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel treatment strategies for feline chronic kidney disease: A critical look at the potential of mesenchymal stem cell therapy.
    Quimby JM; Dow SW
    Vet J; 2015 Jun; 204(3):241-6. PubMed ID: 25933829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis.
    Arzi B; Clark KC; Sundaram A; Spriet M; Verstraete FJM; Walker NJ; Loscar MR; Fazel N; Murphy WJ; Vapniarsky N; Borjesson DL
    Stem Cells Transl Med; 2017 Aug; 6(8):1710-1722. PubMed ID: 28618186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the potential use of adipose-derived mesenchymal stromal cells in the treatment of canine atopic dermatitis: a pilot study.
    Hall MN; Rosenkrantz WS; Hong JH; Griffin CE; Mendelsohn CM
    Vet Ther; 2010; 11(2):E1-14. PubMed ID: 20957613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of stem cell therapies in companion animal practice.
    Kang MH; Park HM
    J Vet Sci; 2020 May; 21(3):e42. PubMed ID: 32476316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell basic research and applications in dog medicine.
    Gugjoo MB; Amarpal A; Sharma GT
    J Cell Physiol; 2019 Aug; 234(10):16779-16811. PubMed ID: 30790282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Endoscopic and histological outcomes.
    Pérez-Merino EM; Usón-Casaús JM; Duque-Carrasco J; Zaragoza-Bayle C; Mariñas-Pardo L; Hermida-Prieto M; Vilafranca-Compte M; Barrera-Chacón R; Gualtieri M
    Vet J; 2015 Dec; 206(3):391-7. PubMed ID: 26526521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunomodulatory properties of equine peripheral blood-derived mesenchymal stem cells in healthy cats.
    Debosschere Y; Depuydt E; Pauwelyn G; Beerts C; Van Hecke L; Verhaert L; Duchateau L; Saunders J; Tack L; Spaas JH
    Vet Immunol Immunopathol; 2020 Sep; 227():110083. PubMed ID: 32563854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programming of metabolic and autoimmune diseases in canine and feline: linkage to the gut microbiome.
    Ji Y; Yang Y; Wu Z
    Microb Pathog; 2023 Dec; 185():106436. PubMed ID: 37913827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes.
    Pérez-Merino EM; Usón-Casaús JM; Zaragoza-Bayle C; Duque-Carrasco J; Mariñas-Pardo L; Hermida-Prieto M; Barrera-Chacón R; Gualtieri M
    Vet J; 2015 Dec; 206(3):385-90. PubMed ID: 26526522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Severe Oral Inflammatory Conditions in Dogs and Cats.
    Anderson JG; Hennet P
    Vet Clin North Am Small Anim Pract; 2022 Jan; 52(1):159-184. PubMed ID: 34838249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scoping review of the use of mesenchymal stem and stromal cell products in cats, Part 2: current scope and efficacy.
    Webb TL; Webb CB
    J Am Vet Med Assoc; 2024 Jun; 262(S1):S24-S30. PubMed ID: 38565137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Research and Use of Mesenchymal Stem Cells in the Therapy of Autoimmune Diseases.
    Chen Y; Yu Q; Hu Y; Shi Y
    Curr Stem Cell Res Ther; 2019; 14(7):579-582. PubMed ID: 31729289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise Review: Stem Cell Trials Using Companion Animal Disease Models.
    Hoffman AM; Dow SW
    Stem Cells; 2016 Jul; 34(7):1709-29. PubMed ID: 27066769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.